George Clinical to Accelerate International Growth Through Acquisition by Hillhouse

SYDNEY, December 9, 2022 – George Clinical announces that it has entered into a sale agreement with Hillhouse, a global investment firm with deep experience in partnering with and supporting healthcare businesses. The transaction will allow George Clinical to continue a path of rapid global expansion, leadership in Asia-Pacific clinical research services, and will provide considerable […]

Read More

December 9th, 2022

George Clinical Recruits More than 5,000 Patients in the Global Kidney Patient Trials Network

OVERLAND PARK, Ks., October 25, 2022 – George Clinical, in close collaboration with The George Institute for Global Health, has recently announced the recruitment of more than 5,000 patients in its ground-breaking, first of its kind, Global Kidney Patient Trials Network (GKPTN) which will accelerate treatments for kidney disease. The concept for the GKPTN is […]

Read More

October 25th, 2022

George Clinical Expands China Team with New Project Director and Cell Gene Therapy Head Helen Xu

BEIJING, September 7, 2022 – George Clinical, a global clinical research organization with an extensive presence throughout the Asia-Pacific region, continues to expand the organization’s team in China with the addition of Helen Xu as Project Director and Cell Gene Therapy Head. She will be based in Beijing and joins a rapidly growing team responsible […]

Read More

September 9th, 2022

Meet Our Team: Gillian Ryan, Global Head, Early Phase Strategy

Gillian Ryan joined George Clinical in the spring of 2021 with over 20 years of experience in the pharmaceutical industry including experience working in, and with, large pharma companies and clinical research organizations, across all phases of drug development and many therapeutic areas. Gillian’s experience spans both project operations and medical affairs and she holds […]

Read More

July 26th, 2022

IBM Highlights George Clinical Data Management Successes

IBM recently highlighted the success George Clinical has enjoyed over the past several years leveraging the firm as a data, analytics and technology partner. The white paper, “Achieving Healthy CRO Growth Through Agility” was published with input from George Clinical Head of Data Management, Ullas Arabhavi. The paper describes how nearly a decade ago, the […]

Read More

July 19th, 2022

George Clinical Earns Bronze Medal from EcoVadis for Sustainability Performance

George Clinical announces that it has achieved a Bronze Medal from EcoVadis, the world’s most trusted provider of business sustainability ratings. This is the first time the organization has pursued certification and earned a medal from EcoVadis. An EcoVadis Rating validates the organization’s business sustainability commitments and performance. George Clinical’s score places the company in […]

Read More

June 6th, 2022

Private Public Partnership to Fast Track Treatments for Rare Cancers Receives Backing from the Australian Government

A new multi-faceted partnership supported by George Clinical will move to the forefront of the cancer treatment revolution. The Precision Oncology Screening Platform Enabling Clinical Trials (PrOSPeCT) will establish Australia as a medical manufacturing hub building links from research through to the clinic; creating jobs and changing lives.  Over the past decade, immunotherapy and other […]

Read More

May 17th, 2022

George Clinical India Collaboration with Project NIRAMAYA

It is a proud moment for George Clinical, India to collaborate with Project NIRAMAYA, a program for “Creation of Livelihood opportunities through Skill Development in the field of ‘Home Nursing’. In its two-fold agenda of providing sustainable healthcare support to the elderly with unmet needs in rural sectors, this program extends social and financial support […]

Read More

March 30th, 2022

CKD3 Summit 2022

The 4th Annual Chronic Kidney Disease Drug Development (CKD3) Summit saw a select group of scientists, clinical researchers and experts from industry and regulatory agencies gathered face-to-face for the first time since the pandemic. Excitement and enthusiasm were evident as these experts networked and collaborated on how the latest scientific research is being applied to […]

Read More

March 30th, 2022

UPcare Group to Commence Human Trials in Australia in the Fight against COVID

The UPcare Group is now advancing to human trials with George Clinical with trials to begin soon. UPcare’s human trials are based on their previous pre-clinical and real-world data. Pre-clinical trial results conducted by The Doherty institute in 2020 indicated that compounds used in UPCare’s formulations and products are up to 99.99% effective at inhibiting […]

Read More

March 15th, 2022

Add George Clinical to your network